Sarcoidosis is a heterogeneous disease in terms of presentation, duration, and severity. Due
to this heterogeneity, it is difficult to align treatment decisions. Biomarkers have proved to be …

Cardiac sarcoidosis is a potentially fatal complication of sarcoidosis. The 1993 guidelines of
the Ministry of Health, Labour, and Welfare (MHLW) of Japan have been used as the …

Sarcoidosis is a systemic granulomatous disease of unknown cause. Sarcoidosis involving
the heart, ie, cardiac sarcoidosis, affects the prognosis of patients significantly as it may lead …

Background There is limited consensus regarding the relative diagnostic performance of
cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac sarcoidosis. Purpose To perform …

Sarcoidosis is a multi-system inflammatory disorder of unknown etiology resulting in
formation of non-caseating granulomas. Cardiac involvement—which is associated with …

This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Aims Cardiac death is the leading cause of mortality in patients with sarcoidosis, yet cardiac
involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) …

Background To study the role of whole-body 18 F-fluorodeoxyglucose (FDG) positron
emission tomography (PET) scans in the identification of occult biopsy sites and reversible …

Purpose To evaluate the interest of 18 F-fluoro-2-deoxy-d-glucose positron emission
tomography/computed tomography (18 F-FDG PET/CT) for diagnosis and therapeutic follow …

Granulomatous lung diseases are a heterogeneous group of disorders that have a wide
spectrum of pathologies with variable clinical manifestations and outcomes. Precise clinical …